Portfolio company Vivasure was acquired by Haemonetics.
JAN 2026
Vivasure Medical develops bio-absorbable polymer implants and delivery systems for minimally invasive large-bore arterial and venous vessel closure
Vivasure Medical develops bio-absorbable polymer implants and delivery systems for minimally invasive large-bore arterial and venous vessel closure. Its PerQseal Elite is a sutureless, patch-based vascular closure system for cardiovascular, interventional radiology, and endovascular procedures. The company operates an integrated R&D and manufacturing facility and was acquired by Haemonetics in January 2026.